Clinical Differentiation
Clinical Differentiation - Related Videos
07:58
Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates
0 Views •
Cited by 10 •
2017
This manuscript describes proper Vibrio cholerae maintenance techniques in addition to a series of biochemical assays, collectively utilized for quick and reliable differentiation between clinical and environmental V. cholerae biotypes in a laboratory setting.
09:52
Embryonic Stem Cell Culture and Differentiation
0 Views •
2023
Culturing embryonic stem (ES) cells requires conditions that maintain these cells in an undifferentiated state to preserve their capacity for self-renewal and pluripotency. Stem cell biologists are continuously optimizing methods to improve the efficiency of ES cell culture, and are simultaneously trying to direct the differentiation of ES cells into specific cell types that could be used in regenerative medicine. This video describes the basic principles of ES cell culture, and demonstrates a...
09:05
Determining the Phagocytic Activity of Clinical Antibody Samples
0 Views •
Cited by 33 •
2011
We present a high-throughput flow cytometric assay to determine the phagocytic activity of antigen-specific antibodies from clinical samples, utilizing fluorescent antigen-coated beads and a monocytic cell line expressing multiple Fc receptors—providing receptor usage and phagocytic activity determinations in a standardized and reproducible fashion for any antigen of interest.
07:50
Establishment of a Clinic-based Biorepository
0 Views •
Cited by 4 •
2017
Cutaneous tumors are often discarded following Mohs micrographic surgery. A protocol is described here that enables clinical support staff to effectively process and store cutaneous tumor (e.g., squamous cell carcinoma, basal cell carcinoma, and melanoma) samples for downstream laboratory applications without interfering with clinical operations.
05:14
Differentiating Immortalized Multipotent Otic Progenitors into Spiral Ganglion Neurons and Evaluating the Differentiation
0 Views •
2025
The video demonstrates the differentiation of immortalized multipotent otic progenitors (iMOPs) into spiral ganglion neurons (SGNs) and immunofluorescence-based confirmation of the differentiation. The iMOPs are plated onto culture substrate-coated coverslips in a neuronal differentiation medium for differentiation into SGNs. The differentiated cells are labeled with antibodies specific for neuronal differentiation markers and analyzed under a microscope to confirm differentiation.
FAQs
Clinical differentiation depends on combining evidence rather than treating any single finding as decisive. History may reveal timing and context, examination adds observable features, risk factors alter plausibility, and tests provide additional support or contradiction. Weighing these elements against competing explanations helps clinicians refine diagnostic priorities while accounting for the full patient presentation.
Risk factors do not establish a diagnosis, but they change how plausible competing explanations appear before or alongside testing. When similar symptoms fit several conditions, this context helps clinicians decide which possibilities deserve closer attention and which investigations may be most informative. It also supports earlier recognition of conditions that could require urgent evaluation.
It creates a structured way to compare serious possibilities with less urgent explanations when symptoms overlap. Clinicians can use the available history, examination findings, risk factors, and test results to decide which explanation needs priority. This emphasis on prioritization can guide timely investigation and treatment, even before every uncertainty is resolved.
The process begins with the patient’s history and physical examination, followed by consideration of relevant risk factors. Clinicians then compare competing explanations and select diagnostic tests that can add useful evidence. Results are interpreted alongside the initial information, allowing diagnostic priorities and treatment decisions to be refined as the overall picture becomes clearer.
Tests are chosen in relation to the competing explanations under consideration, rather than in isolation from the clinical picture. Their results are assessed for whether they support or argue against particular possibilities. This approach links investigation to decision-making, helping clinicians focus on information that can clarify priorities and guide appropriate care.
It supports individualized care because diagnostic reasoning connects a patient’s particular findings and risks with decisions about investigation and treatment. The same reasoning also improves communication across specialties by providing a shared way to explain why some diagnoses are prioritized, others are questioned, and particular next steps are selected.